Clinical trial Recruiting at 1 site Interventional Ages 40 to 75 Women only

Treatment of vaginal atrophy using a low-intensity laser

Official title: Study of the Efficiency and Safety of Low-Intensity Neodymium Laser Radiation With a Nanosecond Pulse Duration for Treatment of the Vaginal Walls Atrophic Changes

Run by MeLSyTech, Ltd · NCT05335317 · Data updated 2026-11-12

This study is testing whether a low-intensity laser treatment can improve vaginal health in postmenopausal women who are dealing with vaginal atrophy.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexWomen only
Enrollment120 (estimated)
SponsorMeLSyTech, Ltd
Industry-sponsored
Drugs / interventionsradiation
Locations1 site (Nizhny Novgorod)
StatusRecruiting
StartedApril 18, 2022
Main results expectedSeptember 1, 2025
Study endsDecember 1, 2025
Registry record updatedDecember 12, 2024
Trial IDNCT05335317 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 40-75 with vaginal atrophy or mild vaginal prolapse.

Probably not a fit

Patients with a history of oncological diseases or severe vaginal prolapse will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effects of low-intensity neodymium laser treatment on the vaginal wall in postmenopausal women experiencing vaginal atrophy. Participants will be divided into three groups: one receiving laser treatment, another receiving topical hormone therapy, and a control group receiving no treatment. Various assessments, including vaginal health indices and imaging techniques, will be conducted before and after treatment to measure changes in vaginal health. The study will involve up to 120 participants, with follow-up visits scheduled after the treatment procedures.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the quality of life for women suffering from vaginal atrophy.

How similar studies have gone: Other studies have shown promising results with laser treatments for vaginal atrophy, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age of 40-75 years, inclusive;
* Vaginal atrophy or 1st grade vaginal prolapse with atrophy, or lack of vaginal atrophy in case of control group 2;
* All participants have informed consent to conduct a course of procedures according to protocol, carry out follow-up visits, and conduct studies.

Exclusion Criteria:

* Age of under 40 and over 75 years old;
* History of oncological diseases;
* Active tuberculosis;
* Inflammatory diseases of the vulva and vagina including genital herpes in the acute stage;
* Urinary tract infections;
* Damage to the vaginal mucosa;
* Pregnancy;
* Tendency to photoallergy including taking photosensitizing drugs (diuretics, antihistamines, antipsychotics);
* Porphyria;
* Cardiac deficiency of 2-3 degrees;
* Chronic renal disease;
* Participants with greater than 1st grade vaginal prolapse;
* Women after childbirth up to 8 weeks;
* Participants who, according to the doctor, are not able to complete the study;
* Protocol non-compliance of laser exposure sessions;
* Voluntary refusal to participate in the study;
* Violation of recommendations for the management of the period after laser treatment;
* Adverse events that occurred during laser processing and research, and associated with them.
* The appearance of contraindications listed in the Exclusion criteria.

Where it's running

  • State-Funded Healthcare Institution of the Nizhny Novgorod region "Nizhny Novgorod Regional Clinical Hospital named after N.A. Semashko"
    Nizhny Novgorod, Russia
    Recruiting

Study contacts

  • Principal investigator: Liya Z Sirotina — Privolzhsky Research Medical University
  • Study coordinator: Ksenia V Shatilova, Ph.D.
  • Email: shatilova@melsytech.com
  • Phone: +79262792700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.